Please assess the completion status of the following clinical trial:

Trial Title: The Erector Spinae Plane Block and Its Effect on Respiratory Status and Pain Management in Rib Fracture Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Blunt chest trauma~* Sustaining at least 3 unliateral rib fractures~* Resultant vital capacity less than 30% predicted~* Pain score reaches threshold despite using the current institutional standard of care for pain control~Exclusion Criteria:~* Patients whose weight less than 60kg.~* Patients with bilateral rib fractures.~* Patients that are intubated and mechanically ventilated.~* Pregnant Individuals.~* Any individual with a documented allergy to ropivacaine.~* Patients with limited English proficiency (LEP)~* Patients whose body habitus prevents the practitioner's ability to adequately perform the procedure.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ESP block with normal saline (Type: SHAM_COMPARATOR): An erector spinae plane block will be performed and a single dose of Normal Saline Flush, 0.9% Injectable Solution will be administered into the target muscle plane.
- ESP block with local anesthetic (Type: EXPERIMENTAL): An erector spinae plane block will be performed and a single dose of 0.5% ropivacaine will be injected into the target muscle plane.

Based on this trial design, predict the completion outcome and termination type (if applicable).